Spots Global Cancer Trial Database for Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
Official Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Compare the Efficacy and Safety of Anlotinib Versus Placebo in Patients With 131I-Refractory Differentiated Thyroid Cancer(ALTER01032)
Study ID: NCT02586337
Conditions
Study Description
Brief Summary: The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Differentiated Thyroid Cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Beijing Tongren Hospital, Beijing, Beijing, China
Peking Union Medical College Hospital, Beijing, Beijing, China
Chongqing Cancer Hospital, Chongqing, Chongqing, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Gansu Province Tumor Hospital, Lanzhou, Gansu, China
Sun Yat-Sen University Cancer Center, Guozhou, Guangdong, China
Harbin medical university affiliated tumor hospital, Harbin, Heilongjiang, China
Henan Province Tumor Hospital, Luoyan, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
Hunan Province Tumor Hospital, Changsha, Hunan, China
Jiangsu province tumor hospital, Nanjing, Jiangsu, China
Jilin Cancer Hospital, Changchun, Jilin, China
Liaoning Province Tumor Hospital, Shenyang, Liaoning, China
Cancer Hospital of Fudan University, Shanghai, Shanghai, China
West China Hospital Of Sichuan University, Chongqing, Sichuan, China
20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital ., Tianjin, Tianjin, China
The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
